Key indices were trading higher as positive Asian stocks boosted sentiment. At 9:22 IST, the barometer index, the S&P BSE Sensex, was up 462.14 points or 1.13% at 41,279.88. The Nifty 50 index was up 141.00 points or 1.17% at 12,166.35.
The S&P BSE Mid-Cap index was up 1.22%. The S&P BSE Small-Cap index was up 1.10%.
The market breadth, indicating the overall health of the market, was positive. On the BSE, 673 shares rose and 80 shares fell. A total of 23 shares were unchanged.
Among stocks, Bharti Airtel rose 1.46%. Bharti Airtel said the company will launch a qualified institutional placement worth $2 billion at an indicative issue floor price of Rs 452.09 per share and a separate fund raising exercise through issue of foreign currency convertible bonds of up to $1 billion. The opening date for both the issue is 8 January 2020.
State Bank of India was up 2.17%. State Bank of India (SBI) announced Residential Builder Finance with Buyer Guarantee (RBBG) to safeguard home buyers financially by issuing guarantee for completion of projects to customers availing SBI Home Loans. Now, customers will be able to secure their investment in the ongoing home projects financed by the bank itself. RBBG will focus on affordable housing segment with home price of upto Rs 2.50 crores in seven Indian geographies initially.
Sunteck Realty jumped 4.93%. Sunteck Realty and State Bank of India (SBI) entered into a Memorandum of Understanding towards boosting the residential housing sector under the Bank's Sapna Aapka - Bharosa SBI Ka scheme with Bank Guarantee to Home Buyers under the Builder Finance scheme.
Vedanta gained 1.05%. Vedanta informed that the company approved offering for subscription, on a private placement basis, up to 20,000 nos. Secured, Rated, Non-Cumulative, Redeemable, Non-Convertible Debentures (NCDs) of face value Rs 10,00,000/- each aggregating up to Rs 2000 crore in one or more tranches.
JSW Energy fell 1.75%. JSW Energy said CARE Ratings has assigned the rating of 'CARE AA-/Credit Watch with Negative implications' for the company's Rs 300 crore non-convertible debenture (NCD) issue. Further, the ratings on the outstanding NCDs are re-affirmed at CARE AA-/Credit Watch with Negative implications.
Alembic Pharmaceuticals advanced 1.87%. Alembic Pharmaceuticals has informed that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations. The inspection was carried out from 6 January, 2020 to 8 January, 2020.
Overseas, Asian stocks were trading higher on Thursday as the United States and Iran backed away from the brink of further conflict in the Middle East and investors reversed their safety plays.
In US, stocks posted gains, with the Nasdaq notching a new record close, after remarks by President Trump suggested the US and Iran were refraining from further military action following attacks on US bases overnight, in retaliation for last week's killing of Maj. Gen. Qassem Soleimani by American forces.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
